Home/Diopter Technologies/Christopher Adams
CA

Christopher Adams

CEO

Diopter Technologies

Therapeutic Areas

Diopter Technologies Pipeline

DrugIndicationPhase
Dissolving Amniotic Membrane Biopolymer Contact LensOcular Surface Disease TreatmentClinical Study Completed
Bioshare Polymer Amniotic Membrane Dissolving DeviceOcular Wounds and Injuries (e.g., corneal injuries, burns)Pre-clinical/Feasibility
PrismX Lens TechnologyEye Diseases (Drug Delivery)Research/Pre-clinical